載入...

Circulating TGFβ in Marfan's Syndrome

BACKGROUND: Marfan syndrome (MFS) is caused by mutations in the fibrillin-1 gene and dysregulation of transforming growth factor β (TGFβ). Recent evidence suggests that losartan, an AT1 blocker that blunts TGFβ activation, may be an effective treatment for MFS. We hypothesized that dysregulation of...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Matt, Peter, Schoenhoff, Florian, Habashi, Jennifer, Holm, Tammy, Van Erp, Christel, Loch, David, Carlson, Olga D., Griswold, Benjamin F., Fu, Qin, De Backer, Julie, Loeys, Bart, Huso, David, McDonnell, Nazli B., Van Eyk, Jennifer E., Dietz, Harry C.
格式: Artigo
語言:Inglês
出版: 2009
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC2779568/
https://ncbi.nlm.nih.gov/pubmed/19635970
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.108.841981
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!